Physician

Yasmeen Khaskia, M.D.

According to 2025 Medicare claims, Yasmeen Khaskia, M.D. (NPI: 1154783827) practices pulmonary disease in the Reading, PA market, with the plurality of this provider's patient population coming from Berks, PA. This provider's primary affiliated billing organization is RESPIRATORY SPECIALISTS LTD (NPI: 1801816152; TIN: 23-2197079) and primary practice location at 19610-3333.

Khaskia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 671 traditional Medicare patients, billed 3,357 HCPCS/CPT codes, and received $195,517 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 780 prescription claims across 201 beneficiaries totaling $303,096 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 356 claims. Open Payments data shows 30 records totaling $817. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $9,495 to $303,096. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$98K$196K2023 Medicare payment: $55,705 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $195,517 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023240597$55,705
20246713,357$195,517

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$152K$303K2016 Drug cost: $9,495 (USD; Tot_Drug_Cst)2017 Drug cost: $73,333 (USD; Tot_Drug_Cst)2018 Drug cost: $57,830 (USD; Tot_Drug_Cst)2019 Drug cost: $38,877 (USD; Tot_Drug_Cst)2020 Drug cost: $2,222 (USD; Tot_Drug_Cst)2021 Drug cost: $47,344 (USD; Tot_Drug_Cst)2022 Drug cost: $100,739 (USD; Tot_Drug_Cst)2023 Drug cost: $93,302 (USD; Tot_Drug_Cst)2024 Drug cost: $303,096 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
201636123$9,495
2017162666$73,333
201893440$57,830
201940164$38,877
2020N/R16$2,222
202123123$47,344
202233175$100,739
202355187$93,302
2024201780$303,096

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$7.4K$15K2023 Medicare payment: $986 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $14,813 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R15$986
2024111356$14,813

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes114117$122
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more161226$92
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes238451$89
94729Test to examine how well the lungs exchange gases109109$28
96160Administration and interpretation of patient-focused health risk assessment159288$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Trelegy ElliptaFluticasone/Umeclidin/Vilanter1665,880$123,732
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr561,890$28,221
Spiriva RespimatTiotropium Bromide211,020$14,504
Stiolto RespimatTiotropium Br/Olodaterol Hcl19630$9,559
Fluticasone-SalmeterolFluticasone Propion/Salmeterol521,860$8,561

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R75$5,132
A7030Full face mask used with positive airway pressure device, eachN1522$1,924
A7031Face mask interface, replacement for full face mask, eachN1627$1,598
E0601Continuous positive airway pressure (cpap) deviceYN/R42$1,579
A4604Tubing with integrated heating element for use with positive airway pressure deviceN2033$1,294

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.30$817AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Yasmeen Khaskia, M.D.?

Tedicare shows public-source Medicare data for Yasmeen Khaskia, M.D. (NPI 1154783827), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yasmeen Khaskia, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Yasmeen Khaskia, M.D.?

Yasmeen Khaskia, M.D. is linked to RESPIRATORY SPECIALISTS LTD (billing NPI 1801816152) in the available physician profile data.

Does Yasmeen Khaskia, M.D. have Open Payments data?

Yasmeen Khaskia, M.D. has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.